The NHS should not deny treatment to patients who pay privately for unapproved drugs, King's Fund chief executive Niall Dickson has said.

He told a seminar yesterday: 'The current practice on top-ups, which prohibits people from privately purchasing drugs not available on the health service while continuing a course of NHS care, is untenable.'

Listen to the debate at